Oregon Public Employees Retirement Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,790	Closed	-$2.52M	–	1582
2023 Q3	$2.52M	Sell	21,790 -9,500	-30%	-$1.02M	0.03%	482
2023 Q2	$3.22M	Buy	+31,290	New	+$3.3M	0.04%	420
2022 Q2	–	Sell	-22,270	Closed	-$2.34M	–	1593
2022 Q1	$2.34M	Buy	22,270 +207	+0.9%	+$20.2K	0.02%	642
2021 Q4	$2.38M	Sell	22,063 -7,600	-26%	-$829K	0.03%	542
2021 Q3	$3.25M	Sell	29,663 -1,522	-5%	-$158K	0.04%	409
2021 Q2	$2.92M	Sell	31,185 -26,256	-46%	-$2.42M	0.03%	457
2021 Q1	$5.29M	Buy	57,441 +305	+0.5%	+$25.7K	0.06%	275
2020 Q4	$4.18M	Buy	+57,136	New	+$4.25M	0.05%	302

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oregon Public Employees Retirement Fund's HZNP Position: Q4 2023 in Review

Oregon Public Employees Retirement Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 21,790 shares — an estimated $2.52M sold.

Oregon Public Employees Retirement Fund first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $5.29M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Oregon Public Employees Retirement Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 21,790 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.52M.
Oregon Public Employees Retirement Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Oregon Public Employees Retirement Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.29M in Q1 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q4 2023, filed 12 Feb 2024.